Wyeth-Ayerst phasing out U.S. infant formula lines in next few months.
This article was originally published in The Tan Sheet
Executive Summary
WYETH-AYERST DISCONTINUING ITS U.S. INFANT FORMULA BUSINESS over the next several months, the American Home Products subsidiary announced Jan. 8. The decision to phase out the specialized infant nutritional lines including SMA, Nursoy and Bonamil in the U.S. and Puerto Rico was made, the company said, in light of Wyeth-Ayerst's "limited presence" in the U.S. infant nutritional market and increasing costs of competing in that market.